|
Pharmacovigilance
|
Adverse Event Reporting
The Pharmacovigilance Service of INTEGRIS Pharma adheres to the Scientific Principles and activities of the Global Pharmacovigilance System. Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. |
|
Pharmacovigilance
|
|
|
Adverse Event Reporting
The Pharmacovigilance Service of INTEGRIS Pharma adheres to the Scientific Principles and activities of the Global Pharmacovigilance System. Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. |
|
| What is an | |
|
Adverse Event ?
Adverse Event (AE), also known as Adverse Reaction, is an unwanted and untoward response in a patient following the administration of a pharmaceutical product, which may or may not have been caused by the treatment with the specific product.
|
|
| Why should you report | |
|
Adverse Events ?
Regardless of your role (healthcare professional, patient, etc.), you can also contribute to making our medicines even safer!
The information you provide helps monitor the safety of products, contributing to the protection of patients and public health. Reporting any Adverse Reaction that occurred with one of our company’s medicinal products will help us monitor the safety profile of this medication more effectively, so that the same Adverse Reactions can be better managed or even prevented in the future. Your information will also enable INTEGRIS Pharma to fulfill reporting obligations to Health Authorities, which require us to provide information about Adverse Events related to our products, even in cases where a causal relationship has not been established. |
|
| How to report an | |
|
Adverse Event
In order to report an Adverse Event related to the use of our company’s product, you can contact our Pharmacovigilance Department as follows:
GREECE By postal mail to: CYPRUS |
|
All information collected within the context of adverse event reporting is confidential, and personal data is recorded anonymously and processed in accordance with the terms of applicable European and local legislation. The information is used solely for the purpose of monitoring the safety of drugs and fulfilling pharmacovigilance obligations.
Finally, regardless of your role, we would like to remind you that you can directly report cases of adverse events to the National Organization for Medicines by submitting a Yellow Card through the following link: http://www.eof.gr/web/guest/yellowgeneral